# MaxCyte, Inc. (MXCT)

> Source: Nexqual · https://nexqual.com/MXCT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, MaxCyte, Inc. (MXCT), nexqual.com/MXCT" · informational, not investment advice.

**Price:** USD 1.3 (+4.00% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.25 · day 1.26–1.31 · 52w 0.64–1.81 · market cap $134M · NMS

## Key facts
- Analysts: Buy (mean 2.17 on a 1–5 scale) (6 analysts), mean target USD 4.11 (range 2.43–5).
- Total return with dividends: 1Y -26.6% vs S&P 500 +18.1%; 5Y -88.2% vs S&P 500 +85.1%.
- Next earnings: 2026-11-10, EPS estimate USD -0.08, revenue estimate $7.5M.

## Analysts
Consensus Buy (mean 2.17 on a 1–5 scale), 6 analysts; mean target USD 4.11 (low 2.43, high 5).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -26.6% | -88.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -26.6% | -34.7% |
| Volatility (annualized) | 69.8% | 64.9% |
| Max drawdown | -61.8% (Oct 2025→Mar 2026) | -94.7% (Nov 2021→Mar 2026) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/MXCT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt